242 related articles for article (PubMed ID: 26219952)
1. Inhibition of NOX1/4 with GKT137831: a potential novel treatment to attenuate neuroglial cell inflammation in the retina.
Deliyanti D; Wilkinson-Berka JL
J Neuroinflammation; 2015 Jul; 12():136. PubMed ID: 26219952
[TBL] [Abstract][Full Text] [Related]
2. Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes.
Gorin Y; Cavaglieri RC; Khazim K; Lee DY; Bruno F; Thakur S; Fanti P; Szyndralewiez C; Barnes JL; Block K; Abboud HE
Am J Physiol Renal Physiol; 2015 Jun; 308(11):F1276-87. PubMed ID: 25656366
[TBL] [Abstract][Full Text] [Related]
3. NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy.
Wilkinson-Berka JL; Deliyanti D; Rana I; Miller AG; Agrotis A; Armani R; Szyndralewiez C; Wingler K; Touyz RM; Cooper ME; Jandeleit-Dahm KA; Schmidt HH
Antioxid Redox Signal; 2014 Jun; 20(17):2726-40. PubMed ID: 24053718
[TBL] [Abstract][Full Text] [Related]
4. Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo.
Jiang JX; Chen X; Serizawa N; Szyndralewiez C; Page P; Schröder K; Brandes RP; Devaraj S; Török NJ
Free Radic Biol Med; 2012 Jul; 53(2):289-96. PubMed ID: 22618020
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent.
Aoyama T; Paik YH; Watanabe S; Laleu B; Gaggini F; Fioraso-Cartier L; Molango S; Heitz F; Merlot C; Szyndralewiez C; Page P; Brenner DA
Hepatology; 2012 Dec; 56(6):2316-27. PubMed ID: 22806357
[TBL] [Abstract][Full Text] [Related]
6. Ebselen by modulating oxidative stress improves hypoxia-induced macroglial Müller cell and vascular injury in the retina.
Tan SM; Deliyanti D; Figgett WA; Talia DM; de Haan JB; Wilkinson-Berka JL
Exp Eye Res; 2015 Jul; 136():1-8. PubMed ID: 25912997
[TBL] [Abstract][Full Text] [Related]
7. NADPH oxidase 1/4 inhibition attenuates the portal hypertensive syndrome via modulation of mesenteric angiogenesis and arterial hyporeactivity in rats.
Deng W; Duan M; Qian B; Zhu Y; Lin J; Zheng L; Zhang C; Qi X; Luo M
Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):255-265. PubMed ID: 30413372
[TBL] [Abstract][Full Text] [Related]
8. Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2-induced intravitreal neovascularization in a rat model of retinopathy of prematurity.
Wang H; Yang Z; Jiang Y; Hartnett ME
Mol Vis; 2014; 20():231-41. PubMed ID: 24623966
[TBL] [Abstract][Full Text] [Related]
9. The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation.
Green DE; Murphy TC; Kang BY; Kleinhenz JM; Szyndralewiez C; Page P; Sutliff RL; Hart CM
Am J Respir Cell Mol Biol; 2012 Nov; 47(5):718-26. PubMed ID: 22904198
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II and aldosterone activate retinal microglia.
Rana I; Suphapimol V; Jerome JR; Talia DM; Deliyanti D; Wilkinson-Berka JL
Exp Eye Res; 2020 Feb; 191():107902. PubMed ID: 31884019
[TBL] [Abstract][Full Text] [Related]
11. Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular disease.
Gray SP; Jha JC; Kennedy K; van Bommel E; Chew P; Szyndralewiez C; Touyz RM; Schmidt HHHW; Cooper ME; Jandeleit-Dahm KAM
Diabetologia; 2017 May; 60(5):927-937. PubMed ID: 28160092
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation.
Lan T; Kisseleva T; Brenner DA
PLoS One; 2015; 10(7):e0129743. PubMed ID: 26222337
[TBL] [Abstract][Full Text] [Related]
13. Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy.
Jha JC; Gray SP; Barit D; Okabe J; El-Osta A; Namikoshi T; Thallas-Bonke V; Wingler K; Szyndralewiez C; Heitz F; Touyz RM; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
J Am Soc Nephrol; 2014 Jun; 25(6):1237-54. PubMed ID: 24511132
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe(-/-) mice.
Di Marco E; Gray SP; Chew P; Koulis C; Ziegler A; Szyndralewiez C; Touyz RM; Schmidt HH; Cooper ME; Slattery R; Jandeleit-Dahm KA
Diabetologia; 2014 Mar; 57(3):633-42. PubMed ID: 24292634
[TBL] [Abstract][Full Text] [Related]
15. Effect of NADPH oxidase 1 and 4 blockade in activated human retinal endothelial cells.
Appukuttan B; Ma Y; Stempel A; Ashander LM; Deliyanti D; Wilkinson-Berka JL; Smith JR
Clin Exp Ophthalmol; 2018 Aug; 46(6):652-660. PubMed ID: 29360265
[TBL] [Abstract][Full Text] [Related]
16. FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic Retinopathy.
Deliyanti D; Zhang Y; Khong F; Berka DR; Stapleton DI; Kelly DJ; Wilkinson-Berka JL
PLoS One; 2015; 10(7):e0134392. PubMed ID: 26222724
[TBL] [Abstract][Full Text] [Related]
17. NAD(P)H oxidase-dependent regulation of CCL2 production during retinal inflammation.
Zhang W; Rojas M; Lilly B; Tsai NT; Lemtalsi T; Liou GI; Caldwell RW; Caldwell RB
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):3033-40. PubMed ID: 19234337
[TBL] [Abstract][Full Text] [Related]
18. The Nox1/4 Dual Inhibitor GKT137831 or Nox4 Knockdown Inhibits Angiotensin-II-Induced Adult Mouse Cardiac Fibroblast Proliferation and Migration. AT1 Physically Associates With Nox4.
Somanna NK; Valente AJ; Krenz M; Fay WP; Delafontaine P; Chandrasekar B
J Cell Physiol; 2016 May; 231(5):1130-41. PubMed ID: 26445208
[TBL] [Abstract][Full Text] [Related]
19. Nox1/4 dual inhibitor GKT137831 attenuates hypertensive cardiac remodelling associating with the inhibition of ADAM17-dependent proinflammatory cytokines-induced signalling pathways in the rats with abdominal artery constriction.
Zeng SY; Yang L; Yan QJ; Gao L; Lu HQ; Yan PK
Biomed Pharmacother; 2019 Jan; 109():1907-1914. PubMed ID: 30551445
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity.
Saito Y; Geisen P; Uppal A; Hartnett ME
Mol Vis; 2007 Jun; 13():840-53. PubMed ID: 17615545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
